about
MCP-1 upregulates amylin expression in murine pancreatic β cells through ERK/JNK-AP1 and NF-κB related signaling pathways independent of CCR2Formyl-peptide receptors revisitedBeta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages.PP2A mediated AMPK inhibition promotes HSP70 expression in heat shock responseThe formylpeptide receptor 2 (Fpr2) and its endogenous ligand cathelin-related antimicrobial peptide (CRAMP) promote dendritic cell maturation.A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.N36, a synthetic N-terminal heptad repeat domain of the HIV-1 envelope protein gp41, is an activator of human phagocytes.Associations of amylin with inflammatory markers and metabolic syndrome in apparently healthy Chinese.TNF-α acutely upregulates amylin expression in murine pancreatic beta cells.Receptor "hijacking" by malignant glioma cells: a tactic for tumor progressionChronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathwayFatty acids induce amylin expression and secretion by pancreatic beta-cells.Formylpeptide receptors mediate rapid neutrophil mobilization to accelerate wound healing.Discovery of Novel Inhibitors and Fluorescent Probe Targeting NAMPT.Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease.The immunopharmacological properties of transforming growth factor beta.Formylpeptide receptor 1 mediates the tumorigenicity of human hepatocellular carcinoma cells.Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis.RNA interference as a novel and powerful tool in immunopharmacological research.Signal relay by CC chemokine receptor 2 (CCR2) and formylpeptide receptor 2 (Fpr2) in the recruitment of monocyte-derived dendritic cells in allergic airway inflammationBiologically active peptides interacting with the G protein-coupled formylpeptide receptor.Toll-like receptors in inflammation of the central nervous system.Resveratrol protects vascular endothelial cells from high glucose-induced apoptosis through inhibition of NADPH oxidase activation-driven oxidative stress.A non-secretory form of FAM3B promotes invasion and metastasis of human colon cancer cells by upregulating Slug expression.High glucose induces renal mesangial cell proliferation and fibronectin expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is inhibited by resveratrol.Proinflammatory stimulants promote the expression of a promiscuous G protein-coupled receptor, mFPR2, in microvascular endothelial cells.HCV peptide (C5A), an amphipathic α-helical peptide of hepatitis virus C, is an activator of N-formyl peptide receptor in human phagocytes.Norepinephrine promotes microglia to uptake and degrade amyloid beta peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme.Hepatic ATF6 Increases Fatty Acid Oxidation to Attenuate Hepatic Steatosis in Mice Through Peroxisome Proliferator-Activated Receptor α.Sesamin inhibits bacterial formylpeptide-induced inflammatory responses in a murine air-pouch model and in THP-1 human monocytes.The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR.Antishock effect of anisodamine involves a novel pathway for activating alpha7 nicotinic acetylcholine receptor.Mechanisms of glucose-induced expression of pancreatic-derived factor in pancreatic beta-cells.Formylpeptide receptor FPR and the rapid growth of malignant human gliomas.Identification of functional domains in the formyl peptide receptor-like 1 for agonist-induced cell chemotaxis.Silencing the formylpeptide receptor FPR by short-interfering RNA.Up-regulation of FPR2, a chemotactic receptor for amyloid beta 1-42 (A beta 42), in murine microglial cells by TNF alpha.Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease.The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1.Desensitization of chemokine receptor CCR5 in dendritic cells at the early stage of differentiation by activation of formyl peptide receptors.
P50
Q21135461-9A1299F0-5084-47C2-9326-A5429DD0E393Q28211007-09424C80-EA83-447F-AB52-D7C6C55F8CA0Q30981919-6D69EF19-0DB3-4E61-9270-DEE9CD21B117Q33721815-0655E5C1-CA9E-4EDF-AD36-D4D1156F7222Q33792925-53C9F2DE-D803-405A-888A-B116A6618F05Q33853280-B00A05C9-69C2-437A-9B42-55994F418B97Q33915808-F7F1020C-6CA3-4747-A459-94619653CBA2Q34026295-6980EEC1-C8C5-4AEE-8872-B3790B677A7BQ34152418-BBA6E9F6-489D-49EA-B41E-EFC45ECCEE06Q34313996-9BBD03EE-F2FA-494E-A519-9991705296ADQ34516226-8C986BD0-E345-42E4-8FB3-035CBEC54ADDQ35008762-8E7E0F1F-56E2-4D24-B25C-E207DA5601F8Q35112909-C6C1F4B8-8FA7-4E88-B457-573B96EA54EDQ35727985-87100CD7-CBC2-4943-BD1C-1061361EDD8EQ36124489-07EEC076-B636-4B0F-912E-49674A282B48Q36308582-E0245139-1062-4CAD-BD82-989A6AA2FFE6Q36711055-1F228A0B-6788-4B99-8A21-A773C457B64DQ36733448-882058DF-D9E9-4DE7-9D7D-BED7F4E1CBCEQ36744886-AFC31611-B64C-48C7-B012-A27C1E5B8285Q36910018-710E8F7E-0677-47FF-9898-C68AB5EB977DQ37018089-72AF0296-657F-492F-BF35-F44827BD8A01Q37877821-D2CF1777-9B61-49C1-BBC7-F33EF670FE8BQ39144504-35FB2C0F-E9D6-47E4-B90B-2FDE9E231A60Q39261026-DA1D5D62-A84F-4E5B-8E65-0E08A275CE73Q39412268-72443604-8F6A-44A3-BC2F-3893629B0D1DQ39506338-4CE7672E-E434-45F0-AA7E-2C98D2A288ECQ39608604-1AEC1ECA-999D-46CF-819B-621C3E226195Q39660802-2394B56B-CF5B-4837-AC8C-7AFB68F7C0DCQ39748140-A6792F8F-C5C8-4662-9007-840DC5A78116Q39759473-7813291A-4DF4-42DF-8480-A64E43D54B84Q39854708-A2CE59EF-D667-491E-8334-11089FF982ECQ39900678-9551C4F7-D5F1-4868-B006-191CEB3EAC97Q40061935-9BFC6176-4956-46CA-AC61-F6C6D18D8C7AQ40414882-33D235E1-3513-4B95-8533-E08F1B7928C8Q40466123-4508E71C-FB53-4925-A9E7-1B8DBDDA2BF0Q40534438-2D9C326F-5BF7-40DA-A993-11DB10F77349Q40701969-875D07DE-B276-478F-8084-6D9432F5EE2AQ43277939-2CAB12B4-6B70-4947-9114-4684E9755EE2Q43600788-1A6E61A6-94A5-4DB8-B692-5D5E0A72C9EFQ43611974-0FDFEDB2-D330-4B84-83C0-759AF784E571
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Yingying Le
@ast
Yingying Le
@en
Yingying Le
@es
Yingying Le
@nl
Yingying Le
@sl
type
label
Yingying Le
@ast
Yingying Le
@en
Yingying Le
@es
Yingying Le
@nl
Yingying Le
@sl
altLabel
Le Y Y
@en
Le Y
@en
Le Yingying
@en
Y Le
@en
Y Y Le
@en
Yingying Le
@en
prefLabel
Yingying Le
@ast
Yingying Le
@en
Yingying Le
@es
Yingying Le
@nl
Yingying Le
@sl
P1053
L-9785-2017
P106
P1153
55236978100
P31
P3829
P496
0000-0002-7990-3899